Piramal Enterprises has received an approval for the issue of secured, rated, redeemable Non-Convertible Debentures (NCDs) on private placement basis up to Rs 200 crore each having a face value of Rs 10,00,000, along with an option to retain oversubscription of up to Rs 100 crore, the total issue size aggregating and not exceeding Rs 300 crore. These Non-Convertible Debentures are proposed to be listed on Wholesale Debi Markel segment of NSE.
The Administrative Committee of the Board of Directors at their meeting held on June 11, 2019, approved the same.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
